First of its kind therapy approved for reducing LDL cholesterol. siRNA Therapy reduced LDL by 50%
First of its kind therapy approved for reducing LDL cholesterol. Leqvio, aka Inclisiran, is the first small interfering…
First of its kind therapy approved for reducing LDL cholesterol. Leqvio, aka Inclisiran, is the first small interfering…
MIT Neuroscientists have identified a specific signal that young children and even babies can use to determine whether…
Researchers reported that putting Medication in bird feeders in places where Culex mosquitoes congregate showed promise in reducing…
A prospective study showed that cataract surgery was linked to a nearly 30% lower risk of dementia in…
Researchers from Brigham and Women’s Hospital found that people who took vitamin D, or vitamin D and omega-3…
B Cells may be holding the secret to fighting chronic viral infections
our resting heart rate can predict the risk of dementia People with RHR of 80 bpm or higher…
A small prospective study in Finland suggested that childhood-onset epilepsy appeared to accelerate brain aging by about 10…
A small randomized trial demonstrated that novel maintenance immunotherapy(VIGIL) provided durable disease control in homologous repair proficient (HRP)…
An experimental HIV vaccine based on mRNA — the same platform technology used in two highly effective COVID-19…